Furthermore, it has been reported that combined treatment with DSF and cisplatin can alter the cellular localization of ATP7A, thereby increasing the drug concentration within tumor cells, promoting apoptosis, and inhibiting tumor growth [256]. The gene discussed is ATP7A; the disease is neoplasm.